LYTIR

Company · XFOR

X4 Pharmaceuticals, Inc.

Name as listed on its exchange; filed with the SEC as X4 Pharmaceuticals, Inc.

Nasdaq's symbol directory lists XFOR on Nasdaq as “X4 Pharmaceuticals, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($12K); insiders sold on 4 occasions ($390K); 1 planned-sale notice; 7 filings by holders of 5% or more; 3 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $12K in total; Insider sales: $390K in total.Jun: Insider sales $36KAug: Insider sales $320KOct: Insider purchases $12KOct: Insider sales $34KDecJanFebMarAprMayJunJulAugSepOctNov$12K$320K
Insider purchases above the line: $12KInsider sales below: $390K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Craig Adam R, Executive Chairman sold on 1 day bought on 1 day latest Oct 16, 2026 sold $211K · bought $12K
  2. Volpone John, President sold on 1 day latest Aug 12, 2026 sold $109K
  3. KIRSKE DAVID, Chief Financial Officer sold on 2 days latest Oct 1, 2026 sold $70K
Every trade (5)
  1. BUYCraig Adam R, Executive Chairman bought Oct 16, 2026 4,600 shares filing $12K
  2. SELLKIRSKE DAVID, Chief Financial Officer sold Oct 1, 2026 11,767 shares filing $34K
  3. SELLCraig Adam R, Executive Chairman sold Aug 12, 2026 47,436 shares filing $211K
  4. SELLVolpone John, President sold Aug 12, 2026 24,576 shares filing $109K
  5. SELLKIRSKE DAVID, Chief Financial Officer sold Jun 30, 2026 8,543 shares filing $36K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. David Kirske filed Oct 1, 2026 Officer 11,767 shares planned sale date 10/01/2026 filing $34K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Venrock Healthcare Capital Partners III, L.P. filed Nov 16, 2026 Schedule 13G/A passive filing 7.6%
  2. Deep Track Capital, LP filed Nov 16, 2026 Schedule 13G/A passive 6,663,821 shares filing 6.58%
  3. Coastlands Capital LP filed Nov 13, 2026 Schedule 13G/A passive filing 9.99%
  4. FMR LLC filed Oct 7, 2026 Schedule 13G/A passive 4,558,616 shares filing 4.6%
  5. Venrock Healthcare Capital Partners III, L.P. filed Sep 21, 2026 Schedule 13G passive filing 5.6%
  6. Deep Track Capital, LP filed Aug 14, 2026 Schedule 13G/A passive 8,040,894 shares filing 8.33%
  7. Perceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive filing 8.1%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Other events filing Oct 29, 2026
  2. Entry into a material definitive agreement; Termination of a material definitive agreement; Creation of a direct financial obligation; Unregistered sales of equity securities; Regulation FD disclosure filing Oct 8, 2026
  3. Other events filing Sep 9, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.